HOLOGIC INC. (US) and BECTON, DICKINSON, AND COMPANY (US) are Leading Players in the Breast Biopsy Devices Market
The global breast biopsy market is projected to reach USD 2.6 billion by 2028 from USD 1.6 billion in 2023, at a CAGR of 10.0 % from 2023 to 2028. The expanding objective includes technological developments, a rise in the use of biopsy instruments, and a rise in the number of biopsy needles, guidance systems, and localization wires.
The breast biopsy market is moderately competitive, with both established companies and upcoming competitors for the same market share. As of 2022, the key player operating in the global breast biopsy market are Hologic Inc. (US), Danaher Corporation (US), Becton Dickinson, and Company (US), Argon Medical Devices (US), Merit Medical Systems (US), Menarini-Silicon Biosystems (Italy), Guardant Health, Inc. (US), NeoGenomics (US), Sysmex Inostics (Germany), Sterylab S.R.L. ( Italy), Biocept, Inc. (US), Bio-Rad Laboratories, Inc. (US), F. Hoffmann-La Roche Ltd (Switzerland), Qiagen (Germany), Exact Sciences Corporation (US).
To know about the assumptions considered for the study download the pdf brochure
The key strategies adopted by the top players in this market in the last four years include product launches & expansions, partnerships, acquisitions, and collaborations. In 2022, a major share of the breast biopsy market was held by Hologic Inc. (US), Danaher Corporation (US), Becton, Dickinson, And Company (US), and Qiagen (Germany).
HOLOGIC INC. (US):
One of the key companies in the market for breast biopsy is Hologic Inc. The business is divided into four segments: skeletal health, G surgical, breast health, and diagnostics. To increase its product offerings in the biopsy market, the company is focusing on R&D and product approvals. Over the last three years, the company has introduced several ground-breaking technologies to expand its instrument division. In 2020, the company introduced Brevera breast biopsy system with Corlumina imaging technology. It is the pioneering breast biopsy solution in the world to combine vacuum-assisted tissue acquisition, real-time imaging verification, and sophisticated post-biopsy handling.
BECTON, DICKINSON, AND COMPANY (US):
Becton Dickinson and Company (BD) develops, produces, and sells reagents, consumables, and medical devices. The company operates through three business segments: BD Medical, BD Life Sciences, and BD Interventional. The company's BD Interventional division sells biopsy products.
In addition to providing services to clients in more than 190 nations, BD operates internationally and partners with other companies to expand its geographic reach. The R&D efforts of BD are also prioritized to create fresh separation solutions.
DANAHER CORPORATION (US):
Danaher Corporation (Danaher) is a global manufacturer and distributor of medical devices with a specialization in the development, manufacture, and marketing of therapeutic and diagnostic products for the early identification and treatment of breast cancer. The business is dedicated to providing cutting-edge tools that improve patient care and advance breast health. Its dedication to enhancing brand recognition, ongoing R&D investments, large customer base, and solid geographic presence are important contributors to its dominant position in this market.
The company also invests in R&D to develop new products and enhance its current portfolio. In 2022, the company released the Mammotome Twin core needle, which is small, lightweight, and designed to improve accuracy. Through the introduction of new products to the market, the company experienced growth in developed and developing markets.
Related Reports:
Breast Biopsy Devices Market by Type (Needles, Tables, Assay kits, Liquid Biopsy), Procedure (CNB, FNAB, VAB, Surgical), Technique (Stereotactic, USG, MRI), Application (Screening, Treatment), End-User (Hospitals, Clinic) & Region - Global Forecast to 2028
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
SEND ME A FREE SAMPLE
